ZHONGSHENGYAOYE(SZ:002317) Xin Lang Cai Jing·2025-10-17 01:30Group 1 - The core point of the news is that Zhongsheng Pharmaceutical experienced a slight decline in stock price and had notable changes in financing activities on October 16, with a net financing outflow of 657.69 million yuan [1] - As of October 16, the total financing and securities lending balance for Zhongsheng Pharmaceutical was 493 million yuan, with a financing balance of 491 million yuan, accounting for 3.38% of the circulating market value, indicating a relatively high level compared to the past year [1] - The company reported a decrease in operating income for the first half of 2025, amounting to 1.3 billion yuan, a year-on-year decline of 4.74%, while the net profit attributable to the parent company increased significantly by 114.96% to 188 million yuan [2] Group 2 - Zhongsheng Pharmaceutical has distributed a total of 2.019 billion yuan in dividends since its A-share listing, with 502 million yuan distributed over the past three years [3] - As of June 30, 2025, the number of shareholders for Zhongsheng Pharmaceutical was 89,900, a decrease of 1.32% from the previous period, while the average circulating shares per person increased by 1.33% to 8,470 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fourth largest shareholder with 9.1731 million shares, marking a new entry, while other funds have reduced their holdings [3]